ACT announces results from three ongoing stem cell clinical trials for macular degeneration

Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide some representative examples of data being collected from patients in its clinical trials for forms of macular degeneration .

http://www.news-medical.net/news/20121109/ACT-announces-results-from-three-ongoing-stem-cell-clinical-trials-for-macular-degeneration.aspx